AbbVie Inc (ABBV)

Fixed asset turnover

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Revenue (ttm) US$ in thousands 56,334,000 55,533,000 55,000,000 54,403,000 54,318,000 55,138,000 56,023,000 56,741,000 58,054,000 57,819,000 57,349,000 56,725,000 56,197,000 55,169,000 53,729,000 50,195,000 45,804,000 40,650,000 36,227,000 34,057,000
Property, plant and equipment US$ in thousands 4,934,000 4,943,000 4,931,000 4,935,000 4,893,000 4,958,000 5,075,000 5,110,000 5,130,000 5,161,000 5,193,000 5,248,000 4,986,000 4,908,000 2,961,000
Fixed asset turnover 11.18 11.33 11.51 11.76 11.82 11.57 11.18 11.00 10.75 10.41 9.67 8.73 8.15 7.38 11.50

December 31, 2024 calculation

Fixed asset turnover = Revenue (ttm) ÷ Property, plant and equipment
= $56,334,000K ÷ $—K
= —

The fixed asset turnover ratio is a financial metric used to evaluate a company's efficiency in generating sales revenue from its investment in fixed assets. A higher fixed asset turnover ratio indicates that a company is effectively utilizing its fixed assets to generate sales.

For AbbVie Inc, the fixed asset turnover ratio has exhibited variations over the past few years. From March 31, 2020, to June 30, 2022, the ratio steadily increased from 11.50 to 11.57, indicating an improvement in the company's efficiency in utilizing its fixed assets to generate sales revenue.

However, there was a slight dip in the ratio in the following quarters up to December 31, 2022, where it reached 11.76, possibly suggesting a temporary slowdown in the utilization of fixed assets for revenue generation.

Subsequently, the ratio declined slightly to 11.51 by March 31, 2023, and further decreased to 11.18 by September 30, 2023. These decreases may indicate a potential decrease in the efficiency of AbbVie Inc in generating sales from its fixed assets during this period.

As of the most recent available data, the fixed asset turnover ratio stood at 11.18 as of September 30, 2023. It is important for investors and analysts to monitor this ratio over time to assess the company's ability to efficiently use its fixed assets to drive revenue growth.


See also:

AbbVie Inc Net Fixed Asset Turnover (Quarterly Data)